Opinion of Brazilian Gynecologists on Hormone Therapy for Menopause and Prescriptive Habits

Menopause Clinical Trial

Official title:

Opinion of Brazilian Gynecologists on Hormone Therapy for Menopause and Prescriptive

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05072756
• Other study ID #: 40147120.8.0000.0082
• Status: Completed
• Start date: April 28, 2021
• Est. completion date: September 4, 2021

Study information

• Verified date: September 2021
• Source: Faculdade de Medicina do ABC
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To evaluate Brazilian gynecologists, through structured online questionnaires, with questions directed to their opinions and prescriptive habits about menopause hormone therapy. Research participants will complete the questionnaires in digital format online.

Description:

There are few Brazilian population studies on the opinion of Brazilian gynecologists about the hormonal therapy of menopause in climacteric women, their prescriptive habits and their views on the availability of treatments offered, demanding better evaluation and justifying efforts to analyze the perception of professionals in this area in our country.

Methods: To assess gynecologists across the country, through structured online questionnaires, with questions aimed at knowing their opinions and prescriptive habits about menopause hormone therapy. Research participants will complete the questionnaires in digital format online. Doctors will be invited to participate by e-mail messages and by social media.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1339
• Est. completion date: September 4, 2021
• Est. primary completion date: September 4, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Brazilian licensed gynecologist doctors

Exclusion Criteria:

• Retired doctors

• Health professionals other than medicine doctor

• Medical specialties other than Gynecology

• Medical employees of the pharmaceutical industry

Related Conditions & MeSH terms

• Hormone Replacement Therapy
• Menopause

Intervention

Other:
• Applying a questionnaire
The participants have to answer a questionnaire addressing their opinion on menopausal hormone replacement therapy

Locations

Country	Name	City	State
Brazil	Centro de Atenção Integral à Saúde da Mulher	São Bernardo do Campo	SP

Sponsors (1)

Lead Sponsor	Collaborator
Faculdade de Medicina do ABC

Country where clinical trial is conducted

Brazil, 

References & Publications (3)

Buhling KJ, von Studnitz FS, Jantke A, Eulenburg C, Mueck AO. Use of hormone therapy by female gynecologists and female partners of male gynecologists in Germany 8 years after the Women's Health Initiative study: results of a survey. Menopause. 2012 Oct;19(10):1088-91. — View Citation

Taylor HS, Kagan R, Altomare CJ, Cort S, Bushmakin AG, Abraham L. Knowledge of clinical trials regarding hormone therapy and likelihood of prescribing hormone therapy. Menopause. 2017 Jan;24(1):27-34. doi: 10.1097/GME.0000000000000711. — View Citation

Yeganeh L, Boyle J, Teede H, Vincent A. Knowledge and attitudes of health professionals regarding menopausal hormone therapies. Climacteric. 2017 Aug;20(4):348-355. doi: 10.1080/13697137.2017.1304906. Epub 2017 Apr 5. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Prescription preference	Answer to the questionnaire addressing gynecologists' prescription habit for menopausal women	At Day 1
Secondary	Knowledge of window of opportunity for hormone replacement therapy	This is to see which proportion of gynecologists know the principle of window of opportunity for menopausal hormone replacement therapy	At Day 1
Secondary	Knowledge of indications and contraindications of hormone replacement therapy	This is to see which proportion of gynecologists know the indications and contraindicationsv of menopausal hormone replacement therapy	At Day 1